Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-25

Clinical Trial Update: Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing lanthanum versus calcium carbonate for vascular abnormalities in patients with chronic kidney disease and hyperphosphatemia; current s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium carbonate (Calcium carbonate)
  • Lanthanum (lanthanum)

Snippet

Sponsor: Osaka University | Conditions: Renal Insufficiency, Chronic, Hyperphosphatemia | Phase 4 | Status: UNKNOWN